 | A1IR0 | Name: | 2-(furan-2-yl)-7-pyridin-4-yl-pyrrolo[2,3-d]pyrimidin-4-amine | Formula: | C15 H11 N5 O | SMILES: | Nc1nc(nc2n(ccc12)c3ccncc3)c4occc4 | InChi: | InChI=1S/C15H11N5O/c16-13-11-5-8-20(10-3-6-17-7-4-10)15(11)19-14(18-13)12-2-1-9-21-12/h1-9H,(H2,16,18,19) | Definition date: | 2024-10-16 | Last modified: | 2025-06-13 | Release date: | 2025-06-18 | Identifier: | 2-(furan-2-yl)-7-pyridin-4-yl-pyrrolo[2,3-d]pyrimidin-4-amine |
|
 | A1IR1 | Name: | 4-(furan-2-yl)-6-(6-imidazol-1-ylpyridin-2-yl)-1,3,5-triazin-2-amine | Formula: | C15 H11 N7 O | SMILES: | Nc1nc(nc(n1)c2cccc(n2)n3ccnc3)c4occc4 | InChi: | InChI=1S/C15H11N7O/c16-15-20-13(19-14(21-15)11-4-2-8-23-11)10-3-1-5-12(18-10)22-7-6-17-9-22/h1-9H,(H2,16,19,20,21) | Definition date: | 2024-10-16 | Last modified: | 2025-06-13 | Release date: | 2025-06-18 | Identifier: | 4-(furan-2-yl)-6-(6-imidazol-1-ylpyridin-2-yl)-1,3,5-triazin-2-amine |
|
 | A1IRL | Name: | [(2~{R})-1-[[(2~{R})-1-[(3,4-dichlorophenyl)amino]-3-methyl-1-oxidanylidene-butan-2-yl]amino]-4-methyl-1-oxidanylidene-pentan-2-yl]phosphonic acid | Formula: | C17 H25 Cl2 N2 O5 P | SMILES: | CC(C)C[CH](C(=O)N[CH](C(C)C)C(=O)Nc1ccc(Cl)c(Cl)c1)[P](O)(O)=O | InChi: | InChI=1S/C17H25Cl2N2O5P/c1-9(2)7-14(27(24,25)26)16(22)21-15(10(3)4)17(23)20-11-5-6-12(18)13(19)8-11/h5-6,8-10,14-15H,7H2,1-4H3,(H,20,23)(H,21,22)(H2,24,25,26)/t14-,15-/m1/s1 | Definition date: | 2024-10-09 | Last modified: | 2025-06-13 | Release date: | 2025-06-18 | Identifier: | [(2~{R})-1-[[(2~{R})-1-[(3,4-dichlorophenyl)amino]-3-methyl-1-oxidanylidene-butan-2-yl]amino]-4-methyl-1-oxidanylidene-pentan-2-yl]phosphonic acid |
|
 | A1IXH | Name: | (2~{R})-2-[[3-[(~{E})-2-[3-(2,3-dihydro-1,4-benzodioxin-6-yl)-2-methyl-phenyl]ethenyl]-4-(trifluoromethyl)phenyl]methylamino]-2-methyl-3-oxidanyl-propanoic acid | Formula: | C29 H28 F3 N O5 | SMILES: | Cc1c(cccc1c2ccc3OCCOc3c2)C=Cc4cc(CN[C](C)(CO)C(O)=O)ccc4C(F)(F)F | InChi: | InChI=1S/C29H28F3NO5/c1-18-20(4-3-5-23(18)21-9-11-25-26(15-21)38-13-12-37-25)7-8-22-14-19(6-10-24(22)29(30,31)32)16-33-28(2,17-34)27(35)36/h3-11,14-15,33-34H,12-13,16-17H2,1-2H3,(H,35,36)/b8-7+/t28-/m1/s1 | Definition date: | 2024-12-19 | Last modified: | 2025-06-13 | Release date: | 2025-06-18 | Identifier: | (2~{R})-2-[[3-[(~{E})-2-[3-(2,3-dihydro-1,4-benzodioxin-6-yl)-2-methyl-phenyl]ethenyl]-4-(trifluoromethyl)phenyl]methylamino]-2-methyl-3-oxidanyl-propanoic acid |
|
 | A1IZP | Name: | (3~{R})-1-[[7-(iminomethyl)-2-[2-methyl-3-[2-methyl-3-[[3-[[(3~{R})-3-oxidanylpyrrolidin-1-yl]methyl]-1,7-naphthyridin-8-yl]amino]phenyl]phenyl]-1,3-benzoxazol-5-yl]methyl]pyrrolidine-3-carboxylic acid | Formula: | C41 H41 N7 O4 | SMILES: | Cc1c(Nc2nccc3cc(CN4CC[CH](O)C4)cnc23)cccc1c5cccc(c5C)c6oc7c(C=N)cc(CN8CC[CH](C8)C(O)=O)cc7n6 | InChi: | InChI=1S/C41H41N7O4/c1-24-32(5-3-7-34(24)40-46-36-17-26(15-30(18-42)38(36)52-40)20-47-13-10-29(22-47)41(50)51)33-6-4-8-35(25(33)2)45-39-37-28(9-12-43-39)16-27(19-44-37)21-48-14-11-31(49)23-48/h3-9,12,15-19,29,31,42,49H,10-11,13-14,20-23H2,1-2H3,(H,43,45)(H,50,51)/b42-18+/t29-,31-/m1/s1 | Definition date: | 2025-01-23 | Last modified: | 2025-06-13 | Release date: | 2025-06-18 | Identifier: | (3~{R})-1-[[7-(iminomethyl)-2-[2-methyl-3-[2-methyl-3-[[3-[[(3~{R})-3-oxidanylpyrrolidin-1-yl]methyl]-1,7-naphthyridin-8-yl]amino]phenyl]phenyl]-1,3-benzoxazol-5-yl]methyl]pyrrolidine-3-carboxylic acid |
|
 | A1JDJ | Name: | 2-(1-methylimidazol-2-yl)ethyl (2~{S})-3-[(5-chloranylthiophen-2-yl)carbonylamino]-2-[[2-ethyl-3-[(3~{S})-3-oxidanyl-2-oxidanylidene-pyrrolidin-1-yl]phenyl]sulfonylamino]propanoate | Formula: | C26 H30 Cl N5 O7 S2 | SMILES: | CCc1c(cccc1[S](=O)(=O)N[CH](CNC(=O)c2sc(Cl)cc2)C(=O)OCCc3nccn3C)N4CC[CH](O)C4=O | InChi: | InChI=1S/C26H30ClN5O7S2/c1-3-16-18(32-12-9-19(33)25(32)35)5-4-6-21(16)41(37,38)30-17(15-29-24(34)20-7-8-22(27)40-20)26(36)39-14-10-23-28-11-13-31(23)2/h4-8,11,13,17,19,30,33H,3,9-10,12,14-15H2,1-2H3,(H,29,34)/t17-,19-/m0/s1 | Definition date: | 2025-05-16 | Last modified: | 2025-06-13 | Release date: | 2025-06-18 | Identifier: | 2-(1-methylimidazol-2-yl)ethyl (2~{S})-3-[(5-chloranylthiophen-2-yl)carbonylamino]-2-[[2-ethyl-3-[(3~{S})-3-oxidanyl-2-oxidanylidene-pyrrolidin-1-yl]phenyl]sulfonylamino]propanoate |
|
 | A1I5P | Name: | methyl 2-azanyl-1~{H}-indole-3-carboxylate | Formula: | C10 H10 N2 O2 | SMILES: | COC(=O)c1c(N)[nH]c2ccccc12 | InChi: | InChI=1S/C10H10N2O2/c1-14-10(13)8-6-4-2-3-5-7(6)12-9(8)11/h2-5,12H,11H2,1H3 | Definition date: | 2025-03-10 | Last modified: | 2025-06-13 | Release date: | 2025-06-18 | Identifier: | methyl 2-azanyl-1~{H}-indole-3-carboxylate |
|
 | A1IDY | Name: | (2~{S})-4-[[(2~{R},3~{S},4~{R},5~{R})-5-(6-aminopurin-9-yl)-3,4-bis(oxidanyl)oxolan-2-yl]methyl-[3-(methylamino)propyl]amino]-2-azanyl-butanoic acid | Formula: | C18 H30 N8 O5 | SMILES: | CNCCCN(CC[CH](N)C(O)=O)C[CH]1O[CH]([CH](O)[CH]1O)n2cnc3c(N)ncnc23 | InChi: | InChI=1S/C18H30N8O5/c1-21-4-2-5-25(6-3-10(19)18(29)30)7-11-13(27)14(28)17(31-11)26-9-24-12-15(20)22-8-23-16(12)26/h8-11,13-14,17,21,27-28H,2-7,19H2,1H3,(H,29,30)(H2,20,22,23)/t10-,11+,13+,14+,17+/m0/s1 | Definition date: | 2024-06-07 | Last modified: | 2025-06-13 | Release date: | 2025-06-18 | Identifier: | (2~{S})-4-[[(2~{R},3~{S},4~{R},5~{R})-5-(6-aminopurin-9-yl)-3,4-bis(oxidanyl)oxolan-2-yl]methyl-[3-(methylamino)propyl]amino]-2-azanyl-butanoic acid |
|
 | A1L3J | Name: | (2~{R},3~{R})-3-methyl-2-oxidanyl-pentanoic acid | Formula: | C6 H12 O3 | SMILES: | CC[CH](C)[CH](O)C(O)=O | InChi: | InChI=1S/C6H12O3/c1-3-4(2)5(7)6(8)9/h4-5,7H,3H2,1-2H3,(H,8,9)/t4-,5-/m1/s1 | Definition date: | 2024-08-06 | Last modified: | 2025-06-13 | Release date: | 2025-06-18 | Identifier: | (2~{R},3~{R})-3-methyl-2-oxidanyl-pentanoic acid |
|
 | A1A3A | Name: | 1,1'-[(2E)-but-2-ene-1,4-diyl]bis{2-[(1-ethyl-3-methyl-1H-pyrazole-5-carbonyl)amino]-7-methoxy-1H-1,3-benzimidazole-5-carboxamide} | Formula: | C36 H40 N12 O6 | SMILES: | Cc1cc(C(=O)Nc2nc3cc(cc(OC)c3n2CC=CCn2c3c(OC)cc(cc3nc2NC(=O)c2cc(C)nn2CC)C(N)=O)C(N)=O)n(CC)n1 | InChi: | InChI=1S/C36H40N12O6/c1-7-47-25(13-19(3)43-47)33(51)41-35-39-23-15-21(31(37)49)17-27(53-5)29(23)45(35)11-9-10-12-46-30-24(16-22(32(38)50)18-28(30)54-6)40-36(46)42-34(52)26-14-20(4)44-48(26)8-2/h9-10,13-18H,7-8,11-12H2,1-6H3,(H2,37,49)(H2,38,50)(H,39,41,51)(H,40,42,52)/b10-9+ | Definition date: | 2024-08-23 | Last modified: | 2025-06-13 | Release date: | 2025-06-18 | Identifier: | 1,1'-[(2E)-but-2-ene-1,4-diyl]bis{2-[(1-ethyl-3-methyl-1H-pyrazole-5-carbonyl)amino]-7-methoxy-1H-1,3-benzimidazole-5-carboxamide} |
|
 | A1A4R | Name: | (3S,4S)-2-(4-tert-butyl-3-chlorophenyl)-3-(2,3-dihydro-1,4-benzodioxin-6-yl)-1-oxo-1,2,3,4-tetrahydroisoquinoline-4-carboxylic acid | Formula: | C28 H26 Cl N O5 | SMILES: | CC(C)(C)c1ccc(cc1Cl)N1C(=O)c2ccccc2C(C(=O)O)C1c1ccc2OCCOc2c1 | InChi: | InChI=1S/C28H26ClNO5/c1-28(2,3)20-10-9-17(15-21(20)29)30-25(16-8-11-22-23(14-16)35-13-12-34-22)24(27(32)33)18-6-4-5-7-19(18)26(30)31/h4-11,14-15,24-25H,12-13H2,1-3H3,(H,32,33)/t24-,25+/m0/s1 | Definition date: | 2024-09-05 | Last modified: | 2025-06-13 | Release date: | 2025-06-18 | Identifier: | (3S,4S)-2-(4-tert-butyl-3-chlorophenyl)-3-(2,3-dihydro-1,4-benzodioxin-6-yl)-1-oxo-1,2,3,4-tetrahydroisoquinoline-4-carboxylic acid |
|
 | A1A4X | Name: | benzyl (3-{5-carbamoyl-2-[(1-ethyl-3-methyl-1H-pyrazole-5-carbonyl)amino]-7-methoxy-1H-1,3-benzimidazol-1-yl}propyl)carbamate | Formula: | C27 H31 N7 O5 | SMILES: | Cc1cc(C(=O)Nc2nc3cc(cc(OC)c3n2CCCNC(=O)OCc2ccccc2)C(N)=O)n(CC)n1 | InChi: | InChI=1S/C27H31N7O5/c1-4-34-21(13-17(2)32-34)25(36)31-26-30-20-14-19(24(28)35)15-22(38-3)23(20)33(26)12-8-11-29-27(37)39-16-18-9-6-5-7-10-18/h5-7,9-10,13-15H,4,8,11-12,16H2,1-3H3,(H2,28,35)(H,29,37)(H,30,31,36) | Definition date: | 2024-09-05 | Last modified: | 2025-06-13 | Release date: | 2025-06-18 | Identifier: | benzyl (3-{5-carbamoyl-2-[(1-ethyl-3-methyl-1H-pyrazole-5-carbonyl)amino]-7-methoxy-1H-1,3-benzimidazol-1-yl}propyl)carbamate |
|
 | A1A7Q | Name: | N-[3-tert-butyl-1-(4-methylphenyl)-1H-pyrazol-5-yl]-N'-{(3M)-3-[2-chloro-4-(morpholin-4-yl)-7H-pyrrolo[2,3-d]pyrimidin-5-yl]phenyl}urea | Formula: | C31 H33 Cl N8 O2 | SMILES: | CC(C)(C)c1cc(NC(=O)Nc2cccc(c2)c2c[NH]c3nc(Cl)nc(N4CCOCC4)c23)n(n1)c1ccc(C)cc1 | InChi: | InChI=1S/C31H33ClN8O2/c1-19-8-10-22(11-9-19)40-25(17-24(38-40)31(2,3)4)35-30(41)34-21-7-5-6-20(16-21)23-18-33-27-26(23)28(37-29(32)36-27)39-12-14-42-15-13-39/h5-11,16-18H,12-15H2,1-4H3,(H,33,36,37)(H2,34,35,41) | Definition date: | 2024-09-17 | Last modified: | 2025-06-13 | Release date: | 2025-06-18 | Identifier: | N-[3-tert-butyl-1-(4-methylphenyl)-1H-pyrazol-5-yl]-N'-{(3M)-3-[2-chloro-4-(morpholin-4-yl)-7H-pyrrolo[2,3-d]pyrimidin-5-yl]phenyl}urea |
|
 | 89R | Name: | fluorinated heme | Formula: | C34 H33 F3 Fe N4 O4 | SMILES: | FC(F)(F)C1=C(CC)C=2C=C3C(C)=C(CCC(=O)O)C4=CC=5C(CCC(=O)O)=C(C)C6=Cc7c(C)c(CC)c8C=C1N=2[Fe](n78)(N6=5)N34 | InChi: | InChI=1S/C34H35F3N4O4.Fe/c1-6-19-16(3)23-12-24-17(4)21(8-10-31(42)43)28(39-24)14-29-22(9-11-32(44)45)18(5)25(40-29)13-27-20(7-2)33(34(35,36)37)30(41-27)15-26(19)38-23 | Definition date: | 2017-05-23 | Last modified: | 2025-06-11 | Release date: | 2017-08-16 | Identifier: | (SP-4-2)-[(21R,23S)-2,18-bis(2-carboxyethyl)-7,12-diethyl-3,13,17-trimethyl-8-(trifluoromethyl)porphine-21,23-diido-kappa~4~N~21~,N~22~,N~23~,N~24~]iron |
|
 | DC | Name: | 2'-DEOXYCYTIDINE-5'-MONOPHOSPHATE | Formula: | C9 H14 N3 O7 P | SMILES: | O=C1N=C(N)C=CN1C2OC(C(O)C2)COP(=O)(O)O | InChi: | InChI=1S/C9H14N3O7P/c10-7-1-2-12(9(14)11-7)8-3-5(13)6(19-8)4-18-20(15,16)17/h1-2,5-6,8,13H,3-4H2,(H2,10,11,14)(H2,15,16,17)/t5-,6+,8+/m0/s1 | Definition date: | 2001-06-01 | Last modified: | 2025-06-10 | Identifier: | 2'-deoxy-5'-cytidylic acid |
|
 | A1AYV | Name: | 2-oxo-2,3-dihydro-1,3-benzoxazole-6-sulfonamide | Formula: | C7 H6 N2 O4 S | SMILES: | NS(=O)(=O)c1ccc2NC(=O)Oc2c1 | InChi: | InChI=1S/C7H6N2O4S/c8-14(11,12)4-1-2-5-6(3-4)13-7(10)9-5/h1-3H,(H,9,10)(H2,8,11,12) | Definition date: | 2024-07-11 | Last modified: | 2025-06-09 | Release date: | 2025-03-26 | Identifier: | 2-oxo-2,3-dihydro-1,3-benzoxazole-6-sulfonamide |
|
 | A1CBE | Name: | N-(4-{[(3aS,4R,6S,6aR)-6-(3-chlorophenyl)-2-propanoyloctahydrocyclopenta[c]pyrrol-4-yl]oxy}phenyl)acetamide | Formula: | C24 H27 Cl N2 O3 | SMILES: | CC(=O)Nc1ccc(cc1)OC1CC(C2CN(CC21)C(=O)CC)c1cccc(Cl)c1 | InChi: | InChI=1S/C24H27ClN2O3/c1-3-24(29)27-13-21-20(16-5-4-6-17(25)11-16)12-23(22(21)14-27)30-19-9-7-18(8-10-19)26-15(2)28/h4-11,20-23H,3,12-14H2,1-2H3,(H,26,28)/t20-,21-,22-,23-/m1/s1 | Definition date: | 2025-05-06 | Last modified: | 2025-06-06 | Release date: | 2025-06-11 | Identifier: | N-(4-{[(3aS,4R,6S,6aR)-6-(3-chlorophenyl)-2-propanoyloctahydrocyclopenta[c]pyrrol-4-yl]oxy}phenyl)acetamide |
|
 | Y7Q | Name: | ~{N}-[2-(7-azanylheptyl)-1-(phenylmethyl)benzimidazol-5-yl]-2,4,6-trimethyl-benzenesulfonamide | Formula: | C30 H38 N4 O2 S | SMILES: | Cc1cc(C)c(c(C)c1)[S](=O)(=O)Nc2ccc3n(Cc4ccccc4)c(CCCCCCCN)nc3c2 | InChi: | InChI=1S/C30H38N4O2S/c1-22-18-23(2)30(24(3)19-22)37(35,36)33-26-15-16-28-27(20-26)32-29(14-10-5-4-6-11-17-31)34(28)21-25-12-8-7-9-13-25/h7-9,12-13,15-16,18-20,33H,4-6,10-11,14,17,21,31H2,1-3H3 | Definition date: | 2023-11-28 | Last modified: | 2025-06-06 | Release date: | 2025-06-11 | Identifier: | ~{N}-[2-(7-azanylheptyl)-1-(phenylmethyl)benzimidazol-5-yl]-2,4,6-trimethyl-benzenesulfonamide |
|
 | A1D87 | Name: | 6-[(6-chloranyl-2-propan-2-yl-indazol-5-yl)amino]-3-[(1-methyl-1,2,4-triazol-3-yl)methyl]-1-[[2,4,5-tris(fluoranyl)phenyl]methyl]pyrimidine-2,4-dione | Formula: | C25 H22 Cl F3 N8 O2 | SMILES: | CC(C)n1cc2cc(NC3=CC(=O)N(Cc4ncn(C)n4)C(=O)N3Cc5cc(F)c(F)cc5F)c(Cl)cc2n1 | InChi: | InChI=1S/C25H22ClF3N8O2/c1-13(2)37-10-15-5-21(16(26)6-20(15)32-37)31-23-8-24(38)36(11-22-30-12-34(3)33-22)25(39)35(23)9-14-4-18(28)19(29)7-17(14)27/h4-8,10,12-13,31H,9,11H2,1-3H3 | Definition date: | 2024-06-12 | Last modified: | 2025-06-06 | Release date: | 2025-06-11 | Identifier: | 6-[(6-chloranyl-2-propan-2-yl-indazol-5-yl)amino]-3-[(1-methyl-1,2,4-triazol-3-yl)methyl]-1-[[2,4,5-tris(fluoranyl)phenyl]methyl]pyrimidine-2,4-dione |
|
 | A1D8R | Name: | (2~{S})-2,4-bis(azanyl)-3,3-dimethyl-butanoic acid | Formula: | C6 H14 N2 O2 | SMILES: | CC(C)(CN)[CH](N)C(O)=O | InChi: | InChI=1S/C6H14N2O2/c1-6(2,3-7)4(8)5(9)10/h4H,3,7-8H2,1-2H3,(H,9,10)/t4-/m1/s1 | Definition date: | 2024-06-06 | Last modified: | 2025-06-06 | Release date: | 2025-06-11 | Identifier: | (2~{S})-2,4-bis(azanyl)-3,3-dimethyl-butanoic acid |
|
 | A1D8S | Name: | (2~{S},4~{S})-4-[(2~{S})-2-azanyl-3-azanylidene-propyl]-5-oxidanylidene-pyrrolidine-2-carboxylic acid | Formula: | C8 H13 N3 O3 | SMILES: | N[CH](C[CH]1C[CH](NC1=O)C(O)=O)C=N | InChi: | InChI=1S/C8H13N3O3/c9-3-5(10)1-4-2-6(8(13)14)11-7(4)12/h3-6,9H,1-2,10H2,(H,11,12)(H,13,14)/b9-3-/t4-,5-,6-/m0/s1 | Synonyms: | (2R)-2-acetamido-3-sulfanyl-propanoic acid | Definition date: | 2024-06-06 | Last modified: | 2025-06-06 | Release date: | 2025-06-11 | Identifier: | (2~{S},4~{S})-4-[(2~{S})-2-azanyl-3-azanylidene-propyl]-5-oxidanylidene-pyrrolidine-2-carboxylic acid |
|
 | A1D8Z | Name: | 3,5-bis(trifluoromethyl)aniline | Formula: | C8 H5 F6 N | SMILES: | Nc1cc(cc(c1)C(F)(F)F)C(F)(F)F | InChi: | InChI=1S/C8H5F6N/c9-7(10,11)4-1-5(8(12,13)14)3-6(15)2-4/h1-3H,15H2 | Synonyms: | 3,5-Di(trifluoromethyl)aniline | Definition date: | 2024-06-11 | Last modified: | 2025-06-06 | Release date: | 2025-06-11 | Identifier: | 3,5-bis(trifluoromethyl)aniline |
|
 | Y8B | Name: | 2,4,6-trimethyl-~{N}-[1-(phenylmethyl)benzimidazol-5-yl]benzenesulfonamide | Formula: | C23 H23 N3 O2 S | SMILES: | Cc1cc(C)c(c(C)c1)[S](=O)(=O)Nc2ccc3n(Cc4ccccc4)cnc3c2 | InChi: | InChI=1S/C23H23N3O2S/c1-16-11-17(2)23(18(3)12-16)29(27,28)25-20-9-10-22-21(13-20)24-15-26(22)14-19-7-5-4-6-8-19/h4-13,15,25H,14H2,1-3H3 | Definition date: | 2023-11-28 | Last modified: | 2025-06-06 | Release date: | 2025-06-11 | Identifier: | 2,4,6-trimethyl-~{N}-[1-(phenylmethyl)benzimidazol-5-yl]benzenesulfonamide |
|
 | A1II4 | Name: | 5-chloranyl-6-methyl-pyrazine-2-carbonitrile | Formula: | C6 H4 Cl N3 | SMILES: | Cc1nc(cnc1Cl)C#N | InChi: | InChI=1S/C6H4ClN3/c1-4-6(7)9-3-5(2-8)10-4/h3H,1H3 | Definition date: | 2024-07-27 | Last modified: | 2025-06-06 | Release date: | 2025-06-11 | Identifier: | 5-chloranyl-6-methyl-pyrazine-2-carbonitrile |
|
 | A1IIH | Name: | 3-[2,2-bis(fluoranyl)-10,12-dimethyl-1$l^{4},3-diaza-2$l^{4}-boratricyclo[7.3.0.0^{3,7}]dodeca-1(12),4,6,8,10-pentaen-4-yl]-~{N}-[2-[2-[[2-[(6-oxidanylidene-7-oxa-2,5-diazaspiro[3.4]octan-2-yl)carbonyl]-2-azaspiro[3.3]heptan-6-yl]methyl]phenoxy]ethyl]propanamide | Formula: | C35 H41 B F2 N6 O5 | SMILES: | CC1=CC(=[N+]2C1=Cc3ccc(CCC(=O)NCCOc4ccccc4CC5CC6(C5)CN(C6)C(=O)N7CC8(COC(=O)N8)C7)n3[B-]2(F)F)C | InChi: | InChI=1S/C35H41BF2N6O5/c1-23-13-24(2)43-29(23)15-28-8-7-27(44(28)36(43,37)38)9-10-31(45)39-11-12-48-30-6-4-3-5-26(30)14-25-16-34(17-25)18-41(19-34)33(47)42-20-35(21-42)22-49-32(46)40-35/h3-8,13,15,25H,9-12,14,16-22H2,1-2H3,(H,39,45)(H,40,46) | Definition date: | 2024-07-17 | Last modified: | 2025-06-06 | Release date: | 2025-06-11 | Identifier: | 3-[2,2-bis(fluoranyl)-10,12-dimethyl-3-aza-1-azonia-2-boranuidatricyclo[7.3.0.0^{3,7}]dodeca-1(12),4,6,8,10-pentaen-4-yl]-~{N}-[2-[2-[[2-[(6-oxidanylidene-7-oxa-2,5-diazaspiro[3.4]octan-2-yl)carbonyl]-2-azaspiro[3.3]heptan-6-yl]methyl]phenoxy]ethyl]propanamide |
|